Primary record
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-sulfamide, ACT-132577
- 库存
- 6,677 克
- 纯度
- 99.7 %
- CAS
- 1103522-45-7
化合物标识与属性
- CAS
- 1103522-45-7
- PubChem CID
- 25099191
- SMILES
- C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br
- Canonical SMILES
- NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1
名称与同义词
- Aprocitentan
- Tryvio
- Macitentan
- 1103522-45-7
- ACT-132577
- aprocitentanum
- N-Despropyl Macitentan
- N-Despropyl-macitentan
- Despropyl Macitentan
- Aprocitentan [USAN]
- Macitentan metabolite m6
- Macitentan Impurity 3
- Macitentan metabolite
- Tryvio (TN)
- MZI81HV01P
- Macitentan Impurity 24
- UNII-MZI81HV01P
- Aprocitentan [WHO-DD]
- RefChem:558448
- Aprocitentan (USAN/INN)
- APROCITENTAN [INN]
- CHEMBL2165326
- CHEBI:76609
- C16H14Br2N6O4S
- orb1299478
- SCHEMBL3646065
- Aprocitentan (ACT-132577)
- SCHEMBL30439551
- GTPL10070
- Aprocitentan (ACT-132577)?
- MFCD28155267
- DTXSID401358931
- GLXC-08039
- ACT 132577
- AMY39078
- BCP28125
- DUB52245
- EX-A4419
- ACT132577
- ARD181519
- BDBM50395672
- WHO 10552
- XH1600
- ZINC95553608
- AKOS028114466
- CS-2687
- CS-T-16586
- DB15059
- NCGC00378592-01
- AC-36529
- AS-82256
- BC600808
- HY-15895
- SY310435
- DB-130379
- A-350
- J3.750.478E
- 5-(4-bromophenyl)-4-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-6-(sulfamoylamino)pyrimidine
- D11441
- D87138
- A922313
- F987627
- BRD-K34843150-001-01-4
- BRD-K34843150-001-02-2
- N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]sulfuric diamide
- Q27146161
- ACT-132577; ACT 132577; ACT132577
- N-(5-(4-BROMOPHENYL)-6-(2-((5-BROMOPYRIMIDIN-2-YL)OXY)ETHOXY)PYRIMIDIN-4-YL)SULFAMIDE
- N0001-008384
- Sulfamide, N-(5-(4-bromophenyl)-6-(2-((5-bromo-2-pyrimidinyl)oxy)ethoxy)-4-pyrimidinyl)-
- 6,6a,6b,11-Tetrahydro-11h-5,6,11-metheno-benzo[a]fluoren
- N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]Sulfamide
- N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]aminosulfonamide
- N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-sulfamide, ACT-132577
- [5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]sulfamide
- 5-(4-bromophenyl)-4-(2-(5-bromopyrimidin-2-yl)oxyethoxy)-6-(sulfamoylamino)pyrimidine
- 5-(4-bromophenyl)-4-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-6-(sulfamoylamino)pyrimidine.
- 5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(sulfamoyl)pyrimidin-4-amine
- n-(5-(4-bromophenyl)-6-(2-((5-bromo-2-pyrimidinyl)oxy)ethoxy)-4-pyrimidinyl)sulfamide
- Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy] ethoxy]-4-pyrimidinyl]
- 845-725-0
- N-(5-(4-BROMOPHENYL)-6-(2-((5-BROMO-2-PYRIMIDINYL)OXY)ETHOXY)-4-PYRIMIDINYL)-SULFAMIDE
- N-(5-(4-Bromophenyl)-6-(2-((5-bromo-2-pyrimidinyl)oxy)ethoxy)-4-pyrimidinyl)sulfuric diamide
- N-(5-(4-bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-yl)aminosulfonamide
- N-(5-(4-BROMOPHENYL)-6-(2-((5-BROMOPYRIMIDIN-2-YL)OXY)ETHOXY)PYRIMIDIN-4-YL)SULFURIC DIAMIDE